Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapy.

Sungjun KimYunyoung ChoiKyobum Kim

Published in: Biomaterials research (2022)

AAL is a potential novel drug for the treatment of pancreatic cancer therapeutic agent. In addition, a continuous supply of drugs above the therapeutic threshold using mPEG-Coa could improve therapeutic efficacy.

Keyphrases

drug induced
stem cells
emergency department
combination therapy
risk assessment
human health
chemotherapy induced